Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1993
12/14/1993US5270047 Local delivery of dipyridamole for the treatment of proliferative diseases
12/14/1993US5270041 Sterols, their fatty acid esters and glucosides; processes for their preparation; spontaneously dispersible agents containing these compounds, and their use for treatment of tumors
12/14/1993US5270031 Dentinal desensitizing compositions
12/14/1993CA2098243A1 Benzimidazole derivatives
12/14/1993CA1325213C Prodrug derivatives of the cardiotonic agent 4-ethyl- 1,3-dihydro-5-¬4-(2-methyl-1h-imidazol-1- yl)benzoyl|-2h-imidazol-2-one
12/14/1993CA1325212C (benzofuran-2-yl) imidazoles having pharmaceutical activity, their salts and relevant production processes
12/14/1993CA1325210C Phenolethanolamines, their use as pharmaceuticals and as growth enhancers for animals and processes for their preparation
12/14/1993CA1325209C Certain 2-substituted adenosine derivatives
12/14/1993CA1325208C Antiparasitic agents
12/14/1993CA1325207C Insecticides and parasiticides
12/14/1993CA1325205C Substituted flavanoid compounds, their salts, their manufacture and medicines containing these materials
12/13/1993CA2098252A1 1,4-di-substituted piperazines, process for preparing them et pharmaceutical compositions containing them
12/13/1993CA2098140A1 Benzyl and benzhydryl alcohols
12/12/1993CA2160768A1 Process for the preparation of clavulanic acid
12/12/1993CA2098168A1 Hydroxamic acid derivatives
12/12/1993CA2098158A1 Biphenyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
12/12/1993CA2098133A1 Phosphinyloxy propanaminium inner salt derivatives
12/12/1993CA2097137A1 Novel estradiol derivative-chlorabucil conjugate, process for preparing the same, and pharmaceutical compositions
12/12/1993CA2096266A1 Method for the prophylaxis and/or treatment of ulceractive gastrointestinal conditions using a potassium activator and compositions for same
12/11/1993CA2098058A1 Fused 1,2,5-oxadiazole-2-oxides
12/11/1993CA2098056A1 Pyrimidofuroxans
12/10/1993CA2098069A1 Diacylglycerol nicotinates, their preparation process and pharmaceutical compositions containing the same
12/09/1993WO1993024660A1 Method for inhibition of viral morphogenesis
12/09/1993WO1993024650A1 Therapeutic compositions
12/09/1993WO1993024647A1 Anti-idiotypic monoclonal antibodies against the lewis y-specific monoclonal antibody br55-2 and their uses
12/09/1993WO1993024640A2 Methods and compositions for in vivo gene therapy
12/09/1993WO1993024510A1 Phosphotriester-type biologically active compounds
12/09/1993WO1993024509A1 Erythromycin derivative
12/09/1993WO1993024505A1 Reducing inflammation by time dependent administration of oligosaccharides glycosides related to blood group determinants
12/09/1993WO1993024500A1 Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
12/09/1993WO1993024499A1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism
12/09/1993WO1993024498A1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism as well as dental calculus and plaque
12/09/1993WO1993024497A1 Thio-substituted cyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
12/09/1993WO1993024496A1 Sulfur-containing phosponate compounds for treating abnormal calcium and phosphate metabolism
12/09/1993WO1993024495A1 Phosphonosulfonate compounds for treating abnormal calcium and phosphate metabolism
12/09/1993WO1993024494A1 Quaternary nitrogen-containing phosphonate compounds, for treating abnormal calcium and phosphate metabolism
12/09/1993WO1993024492A1 Spiro-oxetanes, process for preparing the same and medicaments
12/09/1993WO1993024491A1 Indolocarbazole imides and their use
12/09/1993WO1993024490A1 Use of indolocarbazols in aids treatment
12/09/1993WO1993024486A1 Quinuclidine derivatives as squalene synthetase inhibitors
12/09/1993WO1993024485A1 Oxazole derivatives and their use as antiulcer agents and h2-receptor antagonist
12/09/1993WO1993024481A1 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds and related compounds as antibacterial agents
12/09/1993WO1993024479A1 Novel fluorinated quinolones, process for their preparation and pharmaceutical preparations containing same
12/09/1993WO1993024477A1 Chromone derivative and aldose reductase inhibitor containing the same as active ingredient
12/09/1993WO1993024475A1 Sulphamide derivatives as metalloproteinase inhibitors
12/09/1993WO1993024473A1 7-(2-aminoethyl)-benzothiazolones
12/09/1993WO1993024469A1 PROCESS FOR PRODUCING N-β-HYDROXYALKYL-TRI-N-CARBOXYALKYL-1,4,7,10-TETRAAZACYCLODODECANE AND N-β-HYDROXYALKYL-TRI-N-CARBOXYALKYL-1,4,8,11-TETRAAZACYCLOTETRADECANE DERIVATIVES AND THEIR METAL COMPLEXES
12/09/1993WO1993024466A1 Novel pilocarpine derivatives and process for their preparation
12/09/1993WO1993024462A1 Substituted-hexahydrobenzo[a]phenanthridines
12/09/1993WO1993024461A1 Tetrahydro and perhydro isoquinolin derivatives and therapeutic agents containing them
12/09/1993WO1993024458A1 New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a:cholesterol acyl transferase (acat)
12/09/1993WO1993024457A1 Azavesamicols
12/09/1993WO1993024454A1 High cis beta-carotene composition
12/09/1993WO1993024451A1 Desferrioxamine-b salts and their use as orally effective iron chelators
12/09/1993WO1993024449A1 Peptidyl derivatives and their use as metalloproteinases inhibitors
12/09/1993WO1993024448A1 Amino acid derivative and use thereof
12/09/1993WO1993024149A1 Pharmaceutical powder composition containing non-ionic cellulose ether derivative and a chitin-derived polymer
12/09/1993WO1993024144A1 PREPARATION FOR ACTIVATION OF NATURAL KILLER CELLS (NK-CELLS), SAID PREPARATION CONTAINING INTERFERON-α AND HISTAMINE, SEROTONIN OR SUBSTANCES WITH CORRESPONDING RECEPTOR ACTIVITY
12/09/1993WO1993024134A1 Treatment of cellular hyperproliferation by inhibition of interleukin-1
12/09/1993WO1993024132A1 Solid, storage-stable, germicidal, pre-iodine composition
12/09/1993WO1993024131A1 Phosponocarboxylate compounds for treating abnormal calcium and phosphate metabolism
12/09/1993WO1993024130A1 Drug containing (-)-metriphonate
12/09/1993WO1993024129A1 Composition for treating acne vulgaris
12/09/1993WO1993024128A1 Androgens for stimulating the central nervous system and for treating osteoporosis
12/09/1993WO1993024127A1 Selective cell inactivation in blood
12/09/1993WO1993024126A1 Substituted arginines and substituted homoarginines and use thereof
12/09/1993WO1993024125A1 Δ-8-tetrahydro-cannabinol as antiemetic
12/09/1993WO1993024124A1 Compositions based on histamine h2-receptor antagonists and cationic exchangers complexes
12/09/1993WO1993024123A1 Methods for treating viral infections
12/09/1993WO1993024122A1 Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension
12/09/1993WO1993024121A1 Remedy for glaucoma
12/09/1993WO1993024120A1 USE OF (E)-2-(p-FLUOROPHENETHYL)-3-FLUOROALLYLAMINE IN THE TREATEMENT OF ALZHEIMER'S DISEASE
12/09/1993WO1993024119A1 Use of aminothiophenols in the treatment of disorders associated with the complement system
12/09/1993WO1993024118A1 Dapsone and promin for the treatment of dementia
12/09/1993WO1993024117A2 Medicaments for the treatment of anxiety
12/09/1993WO1993024116A1 Pharmaceutical compositions comprising 5-ht1 receptor agonists and absorption enhancers
12/09/1993WO1993024115A1 Anti-rheumatoid arthritic drugs in the treatment of dementia
12/09/1993WO1993024114A1 Reservoir-type plaster containing ketorolac
12/09/1993WO1993024111A1 Oral decongestant product
12/09/1993WO1993024107A1 Metering spray designed for pernasal application
12/09/1993WO1993024096A2 Use of n-(2-(dimethylamino)ethyl)acridine-4-carboxamide and its analogues for cancer treatment
12/09/1993WO1993024002A1 1-[n-(halo-3-pyridylmethyl)]-n-methylamino-1-alkylamino-2-nitroethylene derivatives for use against fleas on pets
12/09/1993WO1993014750A3 Amino acids useful as inhibitors of the advanced glycosylation of proteins
12/09/1993WO1992021344A3 Modulation of cellular response to external stimuli
12/09/1993DE4218744A1 Verfahren zur Herstellung von N-ß-Hxdroxyalkyl-tri-N-carboxylalkyl-1,4,7,10-tetraazacyclododecan- und N-ß-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivaten und deren Metallkomplexe A process for the preparation of N-ß-Hxdroxyalkyl-tri-N-carboxyalkyl-1,4,7,10-tetraazacyclododecane and N-.beta.-hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecane derivatives and metal complexes thereof
12/09/1993DE4218291A1 Dosierspray für pernasale Applikation Metered spray for application pernasal
12/09/1993DE4218096A1 Spiro-oxetane, Verfahren zu ihrer Herstellung und Arzneimittel Spiro-oxetanes, processes for their preparation and pharmaceutical
12/09/1993CA2136977A1 _-8-tetrahydro-cannabinol as antiemetic
12/09/1993CA2136860A1 Use of n-(2-(dimethylamino)ethyl)acridine-4-carboxamide and its analogues for cancer treatment
12/09/1993CA2136845A1 Pharmaceutical compositions comprising 5-ht1 receptor agonists and absorption enhancers
12/09/1993CA2136819A1 Quaternary nitrogen-containing phosphonate compounds, for treating abnormal calcium and phosphate metabolism
12/09/1993CA2136623A1 Compositions based on histamine h-2 receptor antagonists and cationic exchangers complexes
12/09/1993CA2136548A1 Metrifonate-containing medicament
12/09/1993CA2136449A1 Tetrahydro- and perhydroisoquinoline derivatives and therapeutic compositions containing these
12/09/1993CA2136349A1 Treatment of cellular hyperproliferation by inhibition of interleukin-1
12/09/1993CA2136321A1 Pharmaceutical composition for use in glaucoma treatment
12/09/1993CA2136205A1 Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension
12/09/1993CA2136183A1 Spiro-oxetanes, processes for their production and pharmaceutical agents
12/09/1993CA2135394A1 Desferrioxamine-b salts and their use as orally effective iron chelators
12/09/1993CA2134773A1 Methods and compositions for in vivo gene therapy
1 ... 7146 7147 7148 7149 7150 7151 7152 7153 7154 7155 7156 7157 7158 7159 7160 7161 7162 7163 7164 7165 7166 ... 7860